1999
DOI: 10.1006/exnr.1999.7018
|View full text |Cite
|
Sign up to set email alerts
|

The Regeneration of Peripheral Noradrenergic Nerves after Chemical Sympathectomy in Diabetic Rats: Effects of Nerve Growth Factor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
7
0

Year Published

2002
2002
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 41 publications
1
7
0
Order By: Relevance
“…In OVX rats, substantial numbers of sympathetic axons were present by 12 days after lesion, whereas the rate of reinnervation appeared to slow thereafter and no further increase was observed through 25 days. These findings compare favorably with reports from other peripheral targets with regard to time course for reinnervation and their failure to attain their pre-lesion innervation densities 23,24. Thus, only partial reinnervation of the proximal urethra is achieved in OVX rats.…”
Section: Discussionsupporting
confidence: 82%
“…In OVX rats, substantial numbers of sympathetic axons were present by 12 days after lesion, whereas the rate of reinnervation appeared to slow thereafter and no further increase was observed through 25 days. These findings compare favorably with reports from other peripheral targets with regard to time course for reinnervation and their failure to attain their pre-lesion innervation densities 23,24. Thus, only partial reinnervation of the proximal urethra is achieved in OVX rats.…”
Section: Discussionsupporting
confidence: 82%
“…In addition to regeneration following injury, sympathetic nerves innervating the uterus undergo degeneration and regeneration during each estrous cycle (Zoubina and Smith, 2000). The presence of nerve growth factor (NGF) in the target tissue is important for promoting innervation of during development (Glebova and Ginty, 2004) and reinnervation of a tissue after denervation (Aloe et al, 1985; Gloster and Diamond, 1995; Vo and Tomlinson, 1999). …”
Section: Introductionmentioning
confidence: 99%
“…Treating rats with 6-hydroxydopamine (6-OHDA) effectively models cardiac sympathetic denervation and decreases heart tyrosine hydroxylase activity, which causes a concomitant decrease in heart norepinephrine and dopamine levels (24). Sympathetic denervation of rat heart with 6-OHDA (100 mg/kg ip) may also increase the number of ␤-adrenergic receptors in heart (50), although others have demonstrated no effect of denervation on ␤-adrenergic receptor number (51). A similar level of denervation is accomplished by injecting rats with 6-OHDA (50 mg/kg ip) on two consecutive days, 10 days before studies (20).…”
mentioning
confidence: 99%